Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 1TCr 147.44Cr 129.32Cr 119.39Cr 110.32Cr 209.11Cr 14TCr 213.29Cr 1.44TCr 557.66Cr 6.91TCr 553.66Cr 541.53Cr 24TCr P/E 2026 *
14.9x
P/E 2027 * 12.4x
Enterprise Value 1TCr 147.44Cr 129.32Cr 119.39Cr 110.32Cr 209.11Cr 14TCr 213.29Cr 1.44TCr 557.66Cr 6.91TCr 553.66Cr 541.53Cr 24TCr EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.11x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day+2.06%
1 week+4.63%
Current month+7.63%
1 month-0.56%
3 months-9.56%
6 months-17.19%
Current year-16.89%
1 week 22.52
Extreme 22.52
23.38
1 month 21.22
Extreme 21.22
23.87
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%+4.63%-15.07%-12.88% 147.44Cr
-1.60%+2.02%+56.34%+168.94% 1,08400Cr
-1.44%+3.71%+69.07%+65.40% 63TCr
-0.75%+0.67%+33.18%+86.52% 45TCr
-0.25%-2.28%+28.35%+25.81% 33TCr
-8.83%-10.84%+25.09%+27.33% 30TCr
-0.67%-2.20%+28.34%+45.95% 28TCr
-0.91%-3.45%-27.65%-39.62% 22TCr
-0.03%+1.84%+23.90%+68.30% 20TCr
-0.40%+7.82%+22.29%+82.50% 17TCr
Average -1.24%+2.57%+24.39%+51.83% 36.61TCr
Weighted average by Cap. -1.64%+2.48%+40.14%+85.15%

Financials

2026 *2027 *
Net sales 431.8Cr 63Cr 56Cr 51Cr 47Cr 90Cr 6.08TCr 92Cr 617.84Cr 240.06Cr 2.97TCr 238.34Cr 233.12Cr 10TCr 475.4Cr 70Cr 61Cr 57Cr 52Cr 99Cr 6.69TCr 101.09Cr 680.23Cr 264.3Cr 3.27TCr 262.41Cr 256.66Cr 11TCr
Net income 67Cr 9.91Cr 8.69Cr 8.02Cr 7.41Cr 14Cr 948.6Cr 14Cr 96Cr 37Cr 464.21Cr 37Cr 36Cr 1.61TCr 74Cr 11Cr 9.6Cr 8.87Cr 8.19Cr 16Cr 1.05TCr 16Cr 106.6Cr 41Cr 513.11Cr 41Cr 40Cr 1.78TCr
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
08/26/08 CN¥23.27 +2.06% 51,55,200
07/26/07 CN¥22.80 -1.51% 37,76,101
06/26/06 CN¥23.15 +1.22% 51,55,000
03/26/03 CN¥22.87 +1.19% 41,68,745
02/26/02 CN¥22.60 +1.62% 49,69,360
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.27CNY
Average target price
36.25CNY
Spread / Average Target
+55.78%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock